1372TiPA phase III, randomised, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation in patients with high-risk cutaneous squamous cell carcinoma (CSCC)
Rischin, D, Fury, M G, Lowy, I, Stankevich, E, Li, S, Han, H, Porceddu, S VVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz255.060
Date:
October, 2019
File:
PDF, 80 KB
2019